期刊文献+

中西医结合治疗冠心病不稳定型心绞痛68例临床观察 被引量:3

Combining traditional Chinese and western medicine treatment of coronary heart disease unstable angina 68 cases clinical observation
下载PDF
导出
摘要 目的观察分析中西医结合治疗冠心病不稳定型心绞痛的临床效果.方法:选择2014年1月到2015年1月期间在我院进行治疗的136例冠心病不稳定型心绞痛患者,随机分为观察组和对照组,每组各68例患者,对照组采用单纯西药治疗,观察组在此基础上结合中药进行治疗,对比2组治疗效果.结果:治疗后,观察组治疗的总有效率、心功能指标情况均显著优于对照组,以上差异均具有统计学意义(P〈0.05).结论:冠心病不稳定型心绞痛采用中西医结合疗法治疗,能够有效改善患者的心功能和血脂指标,提高治疗效果,具有临床推广的应用价值. objective to observe the analysis of Chinese and western medicine combined with the clinical effect of treatment of coronary heart disease unstable angina. Methods: from January 2014 to January 2015 in our hospital during the period of treatment of 136 cases of patients with unstable angina, coronary heart disease were randomly divided into observation group and control group, each group, 68 patients in control group adopts pure western medicine treatment, the observation group based on the combination of traditional Chinese medicine (TCM) treatment, compared two groups therapeutic effect. Results: after treatment, to observe the total effective rate of treatment group, cardiac function indexes were significantly better than the control group, the above differences are statistically significant (P 〈 0.05). Conclusion: coronary heart disease (CHD) by the combined therapy of Chinese and western medicine treatment of unstable angina, can effectively improve the cardiac function and blood lipids index of patients, improve the effect of treatment, it has clinical application value.
出处 《世界中医药》 CAS 2015年第A02期1378-1379,共2页 World Chinese Medicine
关键词 中西医结合 冠心病 不稳定型心绞痛 临床效果 combine traditional Chinese and western medicine Coronary heart disease (CHD). Unstable angina Clinical effect
  • 相关文献

二级参考文献34

  • 1施志雄,覃世坚,姜雪冰.辛伐他汀对冠心病患者血液流变性的影响[J].中国血液流变学杂志,2004,14(3):317-318. 被引量:2
  • 2高中芳,杨宝珍.老年冠心病患者血液流变学检测分析[J].中国血液流变学杂志,2006,16(1):100-100. 被引量:22
  • 3张周良,李斌,张黎君,彭旭升,马巍.冠心病患者血液流变性研究[J].中国血液流变学杂志,2006,16(2):270-272. 被引量:33
  • 4柯元南,陈纪林.不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J].中华心血管病杂志,2007,35(4):295-304. 被引量:2146
  • 5胡大一 马长生.心脏病学实践[M].北京:人民卫生出版社,2002.311.
  • 6Blake GJ, Ridker PM. C-reactive protein and other inflammatory risk markers in acute coronary syndromes[J].J Am Coll Cardiol , 2003,41 (4 Suppl S) : 37S-42S.
  • 7Hoffmeister HM, Ehlers R, Buttcher E, et al. Relationship be?tween minor myocardial damage and inflammatory acute-phase re?action in acute coronary syndromes[J].J Thromb Thrombolysis, 2003,15(1):33-39.
  • 8Braunwald E, Antman EM, BeasleyJW, et al. ACC/ AHA guide?line update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--2002: summary article: a report of the American College of Cardiology / American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angi?na)[J]. Circulation, 2002,106(4) : 1893-1900.
  • 9Inoue T,Kato T,Uchida T,et al. Local release of C-reactive pro?tein from vulnerable plaque or coronary arterial wall injured by stenting[J].JAm Coll Cardio!,2005,46(2) :239-245.
  • 10Eggers KM,Lagerqvist B, Venge Pv et al. Prognostic value of bio?markers during and after non-ST-segment elevation acute coro?nary syndrome[J].J Am Coll Cardiol,2009,54(4) :357-364.

共引文献58

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部